
Abstract A set of green, selective, sustainable, and rapid UV spectrophotometric techniques combined with chemometric models was established for the simultaneous estimation of metronidazole (MET), diloxanide furoate (DIL), and mebeverine hydrochloride (MEB) in overlapping binary and ternary mixtures without prior chemical separation. A total of 25 synthetic mixtures were prepared for model development and partitioned into 17 mixtures for calibration and 8 for external validation. Principal component regression (PCR), classical least squares (CLS), and partial least squares (PLS) models were constructed. The PLS framework utilized the SIMPLS algorithm, retaining 3–5 latent variables determined by the minimum root mean square error of cross-validation (RMSECV). PCR retained 4–6 principal components, optimized by cumulative variance and predicted residual error sum of squares (PRESS) minimization. Model validation was performed using RMSE, RMSECV, root mean square error of prediction (RMSEP), and the coefficient of determination ( $${R}^{2}$$ R 2 ), and bias metrics. The optimized PLS model achieved RMSEP values ranging from 0.12 to 0.61 µg mL⁻ 1 . Analytical performance was evaluated using external prediction errors, recovery, precision, and statistical comparison with the reported method. The established chemometric models were successfully applied to synthetic mixtures, pharmaceutical formulations, and drug-spiked human plasma as a proof-of-concept assessment of performance in a complex biological matrix. The overall eco-friendliness of the procedure was additionally verified using comprehensive green metrics, supporting its potential as a sustainable alternative for pharmaceutical quality control and further bioanalytical development.
Rational nanoparticle design, stimuli-responsive release control, and release kinetics matching with changing tissue microenvironment are improving preclinical and clinical regenerative therapy results and clinical translation utilizing artificial intelligence and machine learning. This review is intended to explore the use of interdisciplinary strategies that integrate computational design and experimental validation to advance tissue-focused drug delivery systems. Using AI-enabled procedures to increase encapsulation efficiencies and tunability of release and target engagement has led to the acceleration of the inverse design and closed-loop optimization processes in numerous preclinical models. Unfortunately, sparse metadata and tiny heterogeneous datasets restrained repeatability. Incompetent benchmark repositories, inconsistent reporting, and data sharing pipelines. The regulatory paths for algorithm-informed device-drug products are new and require models, quantification of uncertainty, sterilization validation, and clinical-grade stability data. The pragmatic roadmap emphasizes short-term metadata standards, intermediate community-based benchmarks, and long-term adaptive clinical trials linking computational outcomes with biomarker-driven goals. A consolidated series of technical, translational, and governance recommendations is presented with an actionable checklist made for bridging computational design with clinical translation, such as a synthesis of governance and experiments checklist, which has never been seen before, for faster real-world implementation.
Environmental pollution has increased steadily over the years, posing significant challenges to both ecosystems and human health. Among the major contributors to this problem are the pharmaceutical and chemical industries, which extensively use hazardous chemicals and organic solvents that adversely affect air and water quality. Organic solvents are indispensable in pharmaceutical manufacturing, serving as reaction media during active pharmaceutical ingredient (API) synthesis, purification, analysis, and other processing steps. However, many conventional solvents are toxic, volatile, and environmentally persistent, making their replacement with greener alternatives an urgent priority. This review discusses commonly used hazardous organic solvents and highlights their most suitable green replacements based on their physicochemical properties, performance, and sustainability. Particular emphasis is placed on ionic liquids as promising alternatives to conventional organic solvents because of their negligible vapor pressure, recyclability, and ability to reduce chemical waste. The review also summarizes reactions that have traditionally been performed using hazardous solvents such as pyridine, toluene, and tetrahydrofuran, but have now been successfully carried out using greener solvent systems without compromising reaction efficiency. By providing a comprehensive overview of sustainable solvent alternatives, this review aims to support the adoption of environmentally benign practices in pharmaceutical and chemical research and to encourage the development of greener synthetic methodologies that contribute to environmental protection and sustainable chemistry.
This research aimed to examine the impact of the ethanolic extract of Achillea fragrantissima aerial parts (ACF) on the rat CNS. Forty mature Sprague–Dawley male rats were assigned to four groupings (n = 10): 1st C: (control), 2nd DIZ: (diazepam), 3rd ACF-H: (800 mg/kg extract high-dose extract), and 4th ACF-L: (400 mg/kg low-dose extract) gavaged daily for 14 days. The HPLC-identified components are naringenin, ferulic acid, catechin, chlorogenic acid, diadzein, syringic acid, rutin, hesperetin, kaempferol, caffeic acid, vanillin, and quercetin. The effect of ACF extract on rat CNS was measured using the Open field, Hole-cross, Rotarod, Negative geotaxis, and Wrist-grip tests. ACF extract administration substantially (P < 0.05) reduced locomotor and exploratory behaviors in the open-field and hole-cross tests. In the negative geotaxis test, rats administered ACF extract exhibited a substantial delay (P < 0.05) in the turning 180° to a head-up position. In the rotarod and wrist-grip tests, the fall-off time and the latency to fall were considerably reduced (P < 0.05). Administration of ACF extract significantly (P < 0.05) elevated the brain GABA levels, while the increase in dopamine concentrations was observed but should be interpreted cautiously because these findings require confirmation using more specific analytical methods. Additionally, the extract significantly increased the total antioxidant capacity (TAC), but reduced lipid peroxidation (MDA), 8-hydroxy-2-deoxyguanosine (8OH2dG), and protein carbonyl (PCO) levels. ACF oral administration significantly (P < 0.05) upregulated brain GABAA receptor-linked protein (GABARAP), activity-regulated cytoskeleton-linked protein (ARC), and brain-derived neurotrophic factor (BDNF), meanwhile, significantly downregulated the monoamine oxidase A (MAOA) brain levels. For the first time, the outcomes of the ongoing trial demonstrated the in vivo promising effects of A. fragrantissima aerial parts ethanolic extract on neurobehavioral and antioxidant status in an animal model.
CYP3A4 is the primary cytochrome P450 that plays a secondary role along with CYP2E1 in the oxidation of acetaminophen (APAP) to the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI). APAP overdosing activates c-Jun N-terminal kinase (JNK), which activates the mitochondrial membrane permeability transition (MPT). This cascade results in disruption of the hepatic homeostasis. Initially, 70 compounds were short-listed and considered for molecular docking with CYP3A4. Solanine, having shown the highest docking score (− 11.2), was considered as a potential drug, and the ethanolic extract of the fruits of Solanum tuberosum was prepared from pulp and peel. Cytotoxicity of the pulp and peel extracts on Hep-G2 cells was assessed by MTT assay, colony formation assay, and DAPI staining. In the next phase, 14-day-old pathogen-free, fertilised chicken eggs were procured and inoculated with 100μL of APAP (0.01 mg/ml concentration), 10